查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951704

2026年全球診斷酵素市場報告

Diagnostic Enzyme Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，診斷酵素市場成長顯著，預計到2025年將達到44.9億美元，到2026年將達到47.5億美元，複合年成長率為5.7%。過去幾年成長要素包括高純度診斷酶供應有限、對傳統檢測方法的依賴、慢性病發病率上升、生物技術和研究活動的擴展以及人們對基於酶的診斷方法的認知不斷提高。

預計未來幾年，診斷酵素市場將維持強勁成長，到2030年市場規模將達到63.9億美元，複合年成長率（CAGR）為7.7%。預測期內的成長要素包括：先進酵素工程技術的開發、診斷技術與數位健康平台的整合、就地檢驗（POC​​T）的日益普及、製藥和生物技術領域研發投入的增加，以及政府和私人對診斷創新投入的不斷成長。預測期內的主要趨勢包括：酶基診斷試劑盒的廣泛應用、個人化醫療和生物標記檢測的發展、研究和生物技術應用的不斷拓展、對高特異性和高靈敏度酶的需求不斷成長，以及酶診斷技術在就地檢驗中的應用。

預計未來幾年，慢性病盛行率的不斷上升將推動診斷酶市場的成長。慢性病是指持續超過三個月的長期健康狀況。診斷酶在慢性病和其他疾病的診斷和持續監測中發揮關鍵作用，它能夠幫助醫療專業人員評估疾病嚴重程度、追蹤治療效果，並對治療方案進行合理的調整。例如，根據美國國家醫學圖書館截至2023年1月的數據，預計到2050年，美國50歲及以上至少有一種慢性病的人口數量將增加99.5%，從7152.2萬人增加至1.4266億人。因此，慢性病負擔的加重正在推動診斷酶市場的擴張。

為了滿足臨床診斷（尤其是腫瘤和傳染病檢查）對高靈敏度和絕對定量日益成長的需求，診斷酶市場的主要企業正日益關注數位PCR平台等技術創新。數位PCR (dPCR) 技術將樣本分割成數千個奈米升級反應，無需標準曲線即可對目標核酸進行精確的絕對定量。與依賴參考標準且可能缺乏低濃度目標精確度的傳統定量PCR不同，dPCR具有更高的準確性。例如，2024年9月，總部位於德國的生技公司凱傑(QIAGEN NV)宣布推出其臨床級dPCR平台－QIAcuityDx數位PCR系統。該系統將分割、熱循環和成像整合於單一自動化設備中，可對DNA和RNA進行精確定量，適用於液態生物檢體等癌症監測應用。該平台已獲得歐洲體外診斷醫療器材法規 (IVDR) 認證、美國 510(k) 豁免，並配備直覺易用的軟體、靈活的排程安排，以及透過 GeneGlobe 平台提供的伴隨診斷開發支援。 QIAcuityDx 系統透過減少人工干預來提高實驗室效率，即使在目標分子濃度較低的情況下也能提供一致可靠的結果。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球診斷酵素市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 酵素法診斷試劑盒的廣泛應用
    • 個人化醫療和生物標記發現的發展
    • 拓展研究與生物技術應用
    • 對高特異性和高靈敏度酵素的需求日益成長
    • 將酵素診斷技術整合到即時檢測中

第5章 終端用戶產業市場分析

  • 製藥公司
  • 研究所
  • 生技公司
  • 醫院和診斷中心
  • 學術和臨床研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球診斷酵素市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球診斷酵素市場規模、對比及成長率分析
  • 全球診斷酵素市場表現：規模與成長，2020-2025年
  • 全球診斷酵素市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 碳水化合物分解酶、聚合酵素和核酸酶、蛋白酶以及其他產物類型
  • 按來源
  • 動物、微生物、植物
  • 透過使用
  • 生物催化、診斷、製藥、研究和生物技術
  • 按類型細分：碳水化合物分解酶
  • 澱粉酶、纖維素酶、乳糖酶、Glucosidase
  • 按類型細分：聚合酵素和核酸酶
  • DNA聚合酵素、RNA聚合酵素、限制性內切酶、核酸外切酶
  • 按類型細分：蛋白酶
  • 絲胺酸蛋白酶、半胱氨酸蛋白酶、金屬蛋白酶、天門冬胺酸蛋白酶
  • 按類型細分：其他產品類型
  • 氧化還原酶、轉移酶、解離酶、水解酵素

第10章 區域與國家分析

  • 全球診斷酵素市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球診斷酵素市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 診斷酵素市場：競爭格局及市場佔有率（2024年）
  • 診斷酵素市場：公司估值矩陣
  • 診斷酵素市場：公司概況
    • Sanofi SA
    • Advanced Enzymes Technologies
    • Aldevron LLC
    • Amano Enzymes Inc.
    • Codexis Inc.

第37章：其他領先和創新企業

  • EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年診斷酵素市場：提供新機會的國家
  • 2030年診斷酵素市場：充滿新機會的細分市場
  • 2030年診斷酵素市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: PH4MDENZ02_G26Q1

Diagnostic enzymes are enzymes that are used either directly or as components of assay systems to identify the presence or absence of various compounds, helping to detect, diagnose, or predict the progression of disease conditions. They are widely applied in diagnostics due to their high substrate specificity and measurable activity, even in the presence of other proteins.

The primary product types in the diagnostic enzymes market include carbohydrases, polymerases, nucleases, proteases, and others. Carbohydrases are a class of enzymes, such as amylase, that facilitate the breakdown or synthesis of carbohydrates, including disaccharides. These enzymes are sourced from animals, microorganisms, and plants and are used across applications such as biocatalysts, diagnostics, pharmaceuticals, research, and biotechnology.

Tariffs have impacted the diagnostic enzyme market by raising costs for imported high-purity enzymes, reagents, and laboratory equipment, particularly affecting segments like polymerases, nucleases, and proteases. Regions such as North America and Europe, which depend heavily on imports from Asia-Pacific manufacturing hubs, are most affected. While tariffs have increased operational costs and slowed procurement, they have also incentivized local enzyme production, development of cost-effective alternatives, and innovation in diagnostic assay technologies.

The diagnostic enzyme market research report is one of a series of new reports from The Business Research Company that provides diagnostic enzyme market statistics, including diagnostic enzyme industry global market size, regional shares, competitors with a diagnostic enzyme market share, detailed diagnostic enzyme market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic enzyme industry. This diagnostic enzyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diagnostic enzyme market size has grown strongly in recent years. It will grow from $4.49 billion in 2025 to $4.75 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to limited availability of high-purity diagnostic enzymes, reliance on traditional assay methods, increasing prevalence of chronic diseases, growing biotechnology and research initiatives, rising awareness of enzyme-based diagnostics.

The diagnostic enzyme market size is expected to see strong growth in the next few years. It will grow to $6.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of advanced enzyme engineering techniques, integration of diagnostics with digital health platforms, rising adoption of point-of-care testing, expansion of pharmaceutical and biotech R&D, increasing government and private funding for diagnostic innovations. Major trends in the forecast period include rising adoption of enzyme-based diagnostic kits, growth in personalized medicine and biomarker detection, expansion of research and biotechnology applications, increasing demand for high-specificity and sensitive enzymes, integration of enzyme diagnostics in point-of-care testing.

The increasing prevalence of chronic diseases is expected to drive the growth of the diagnostic enzymes market in the coming years. Chronic diseases are long-term health conditions that persist for three months or longer. Diagnostic enzymes play a critical role in the diagnosis and ongoing monitoring of chronic diseases and other medical conditions by enabling healthcare professionals to evaluate disease severity, track treatment effectiveness, and make informed adjustments to care plans. For example, in January 2023, according to the National Library of Medicine, a US-based agency, the population in the United States aged 50 years and older with at least one chronic condition is projected to rise by 99.5%, increasing from 71.522 million to 142.66 million by 2050. Therefore, the growing burden of chronic diseases is contributing to the expansion of the diagnostic enzymes market.

Major companies operating in the diagnostic enzymes market are increasingly emphasizing technological innovations, such as digital PCR platforms, to address the rising demand for highly sensitive and absolute quantification in clinical diagnostics, particularly in oncology and infectious disease testing. Digital PCR (dPCR) is a technique that divides a sample into thousands of nanoliter-scale reactions, enabling precise absolute quantification of target nucleic acids without the need for standard curves. Unlike traditional quantitative PCR, which relies on reference standards and may lack accuracy at low target levels, dPCR delivers greater precision. For instance, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, launched the QIAcuityDx Digital PCR System, a clinical-grade dPCR platform. This system combines partitioning, thermocycling, and imaging within a single automated device, allowing accurate DNA and RNA quantification for applications such as liquid biopsy-based cancer monitoring. The platform features IVDR certification in Europe, 510(k) exemption in the United States, intuitive software, flexible scheduling, and support for companion diagnostic development through the GeneGlobe platform. The QIAcuityDx system improves laboratory efficiency by reducing manual handling while delivering consistent and reliable results, even for low-abundance targets.

In January 2023, SD Biosensor Inc., a South Korea-based provider of in vitro diagnostic platforms and rapid testing systems, together with its partner SJL Services Private Limited, acquired Meridian Bioscience Inc. for $1.53 billion. Through this acquisition, SD Biosensor sought to accelerate its expansion into the US in vitro diagnostics market by leveraging Meridian Bioscience's established regulatory expertise and distribution network. Meridian Bioscience Inc. is a US-based company specializing in diagnostic testing solutions and life-science raw materials.

Major companies operating in the diagnostic enzyme market are Sanofi S.A., Advanced Enzymes Technologies, Aldevron LLC, Amano Enzymes Inc., Codexis Inc., EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson, AbbVie Inc., Amgen Inc., Biogen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc.

North America was the largest region in the enzymes market in 2025. Middle East is expected to be the fastest-growing region in the diagnostic enzyme market report during the forecast period. The regions covered in the diagnostic enzyme market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic enzyme market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic enzymes market consists of sales of acid phosphatase, alanine aminotransferase, cholinesterase, and aspartate aminotransferase. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the diagnostic enzymes market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Enzyme Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses diagnostic enzyme market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic enzyme ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic enzyme market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Carbohydrases; Polymerases And Nucleases; Protease; Other Product Types
  • 2) By Source: Animals; Microorganisms; Plants
  • 3) By Application: Biocatalysts; Diagnostics; Pharmaceuticals; Research & Biotechnology
  • Subsegments:
  • 1) By Carbohydrases: Amylases; Cellulases; Lactases; Glucosidases
  • 2) By Polymerases And Nucleases: DNA Polymerases; RNA Polymerases; Restriction Endonucleases; Exonucleases
  • 3) By Protease: Serine Proteases; Cysteine Proteases; Metalloproteases; Aspartic Proteases
  • 4) By Other Product Types: Oxidoreductases; Transferases; Lyases; Hydrolases
  • Companies Mentioned: Sanofi S.A.; Advanced Enzymes Technologies; Aldevron LLC; Amano Enzymes Inc.; Codexis Inc.; EKF Diagnostic; Kaneka Eurogentec; Roche Holding AG; Sekisui Diagnostics LLC; Thermo Fisher Scientific Inc.; Charles River Laboratories; Biocatalysts; Merck & Co. Inc.; Chr. Hansen; Kerry Group; Dyadic International; Creative Enzymes; Pfizer Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Johnson & Johnson; AbbVie Inc.; Amgen Inc.; Biogen Inc.; Gilead Sciences Inc.; Regeneron Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Diagnostic Enzyme Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Diagnostic Enzyme Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Diagnostic Enzyme Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Diagnostic Enzyme Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Enzyme-Based Diagnostic Kits
    • 4.2.2 Growth In Personalized Medicine And Biomarker Detection
    • 4.2.3 Expansion Of Research And Biotechnology Applications
    • 4.2.4 Increasing Demand For High-Specificity And Sensitive Enzymes
    • 4.2.5 Integration Of Enzyme Diagnostics In Point-Of-Care Testing

5. Diagnostic Enzyme Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Research Laboratories
  • 5.3 Biotechnology Companies
  • 5.4 Hospitals And Diagnostic Centers
  • 5.5 Academic And Clinical Research Institutions

6. Diagnostic Enzyme Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Diagnostic Enzyme Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Diagnostic Enzyme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Diagnostic Enzyme Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Diagnostic Enzyme Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Diagnostic Enzyme Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Diagnostic Enzyme Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Diagnostic Enzyme Market Segmentation

  • 9.1. Global Diagnostic Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carbohydrases, Polymerases And Nucleases, Protease, Other Product Types
  • 9.2. Global Diagnostic Enzyme Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Animals, Microorganisms, Plants
  • 9.3. Global Diagnostic Enzyme Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology
  • 9.4. Global Diagnostic Enzyme Market, Sub-Segmentation Of Carbohydrases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Amylases, Cellulases, Lactases, Glucosidases
  • 9.5. Global Diagnostic Enzyme Market, Sub-Segmentation Of Polymerases And Nucleases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • DNA Polymerases, RNA Polymerases, Restriction Endonucleases, Exonucleases
  • 9.6. Global Diagnostic Enzyme Market, Sub-Segmentation Of Protease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serine Proteases, Cysteine Proteases, Metalloproteases, Aspartic Proteases
  • 9.7. Global Diagnostic Enzyme Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oxidoreductases, Transferases, Lyases, Hydrolases

10. Diagnostic Enzyme Market Regional And Country Analysis

  • 10.1. Global Diagnostic Enzyme Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Diagnostic Enzyme Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Diagnostic Enzyme Market

  • 11.1. Asia-Pacific Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Diagnostic Enzyme Market

  • 12.1. China Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Diagnostic Enzyme Market

  • 13.1. India Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Diagnostic Enzyme Market

  • 14.1. Japan Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Diagnostic Enzyme Market

  • 15.1. Australia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Diagnostic Enzyme Market

  • 16.1. Indonesia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Diagnostic Enzyme Market

  • 17.1. South Korea Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Diagnostic Enzyme Market

  • 18.1. Taiwan Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Diagnostic Enzyme Market

  • 19.1. South East Asia Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Diagnostic Enzyme Market

  • 20.1. Western Europe Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Diagnostic Enzyme Market

  • 21.1. UK Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Diagnostic Enzyme Market

  • 22.1. Germany Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Diagnostic Enzyme Market

  • 23.1. France Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Diagnostic Enzyme Market

  • 24.1. Italy Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Diagnostic Enzyme Market

  • 25.1. Spain Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Diagnostic Enzyme Market

  • 26.1. Eastern Europe Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Diagnostic Enzyme Market

  • 27.1. Russia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Diagnostic Enzyme Market

  • 28.1. North America Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Diagnostic Enzyme Market

  • 29.1. USA Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Diagnostic Enzyme Market

  • 30.1. Canada Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Diagnostic Enzyme Market

  • 31.1. South America Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Diagnostic Enzyme Market

  • 32.1. Brazil Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Diagnostic Enzyme Market

  • 33.1. Middle East Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Diagnostic Enzyme Market

  • 34.1. Africa Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Diagnostic Enzyme Market Regulatory and Investment Landscape

36. Diagnostic Enzyme Market Competitive Landscape And Company Profiles

  • 36.1. Diagnostic Enzyme Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Diagnostic Enzyme Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Diagnostic Enzyme Market Company Profiles
    • 36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Advanced Enzymes Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Aldevron LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Amano Enzymes Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Codexis Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Diagnostic Enzyme Market Other Major And Innovative Companies

  • EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company

38. Global Diagnostic Enzyme Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Diagnostic Enzyme Market

40. Diagnostic Enzyme Market High Potential Countries, Segments and Strategies

  • 40.1 Diagnostic Enzyme Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Diagnostic Enzyme Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Diagnostic Enzyme Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer